Work

Testosterone, HIV, and cardiovascular disease risk

Year: 2020

Type: article

Abstract: There has been a recent increase in the use of testosterone supplementation among young adults in the United States, despite the controversy of testosterone replacement therapy (TRT) and cardiovascular safety. The lower testosterone levels and earlier age of TRT use in persons living with HIV (PLHIV) is of particular relevance for this population because cardiovascular disease (CVD) comorbidities are known to be increased among PLHIV. There is very limited data on TRT in PLHIV, as such, in this article, we sought to compile current evidence regarding the diagnosis and management of testosterone deficiency and its link to CVD risk including among PLHIV.

Source: Cardiovascular Endocrinology & Metabolism

DOI: 10.1097/xce.0000000000000236

Authors: Jelani K. Grant, Quentin Loyd, Claudia Martinez

Institutions: University of Miami, Jackson Memorial Hospital, University of Miami Hospital

Language: English

Topic: Hormonal and reproductive studies

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3092333882

FWCI: 0.318

Cites: 72

Cited by: 4

Related to: 10